Alnylam Pharmaceuticals (ALNY) Q4 2025 Earnings

30OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.89
0.02
0.93
1.84

Details

Expected EPS
0.560954
Actual EPS
1.84
Surprise EPS
1.28
Surprise Percent
+228.01%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of 1.84 per share for Q4 2025.

0 Comments

Share your thoughts